z-logo
open-access-imgOpen Access
Study on Pegylation of Therapuetic Enzyme Uricase And Its Physio-Chemical Properties For Improving Its Pharmaceutical Characteristics
Author(s) -
Pooja Nanda,
P.E.Jagdeesh Babu
Publication year - 2013
Publication title -
international journal of pharmacology and pharmaceutical technology
Language(s) - English
Resource type - Journals
ISSN - 2277-3436
DOI - 10.47893/ijppt.2013.1010
Subject(s) - pegylation , urate oxidase , allantoin , chemistry , peg ratio , polyethylene glycol , uric acid , enzyme , conjugate , biochemistry , combinatorial chemistry , organic chemistry , mathematical analysis , mathematics , finance , economics
Uricase (urate oxidase EC 1.7.3.3, UC) catalyses t h oxidation of uric acid, a final product of purin e catabolism to allantoin. In the present work, Uricase is bioconju gated using PEG (Polyethylene glycol) as a chemical tool for linking for obtaining conjugates with better and desirable pharmaceutical properties. Uricase from Bacillus fastidisous (Uc) was modified through PEGylation considering various concentrations of li near polyethyleneglycol-8KDa (PEG-8K). The Uc-PEG 8 K conjugates, formed by conjugating Uc and PEG-8K in the ratio of 1:15 r etained 87.5% of the initial uricolytic activity, a nd were highly stable at pH 6.0, which is quiet close to physiological pH and at a t emperature of 16°C.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom